Download
s40795-017-0187-6.pdf 526,60KB
WeightNameValue
1000 Titel
  • Effect of lysine supplementation on hypertensive men and women in selected peri-urban community in Ghana
1000 Autor/in
  1. Vuvor, Frederick |
  2. Mohammed, Husein |
  3. Ndanu, Thomas |
  4. Harrison, Obed |
1000 Erscheinungsjahr 2017
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2017-07-27
1000 Erschienen in
1000 Quellenangabe
  • 3:67
1000 Copyrightjahr
  • 2017
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s40795-017-0187-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050943/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • BACKGROUND: Lysine is one of the essential amino acids and in cereal based diets it is known to be the most limiting and therefore determines the quality of dietary protein in such diets. This study investigated the effect of lysine supplementation on blood pressure of hypertensive adults in selected peri-urban community in Accra, Ghana. METHODS: The study was a randomized double-blind controlled study made up of adults men and women assigned to a lysine supplemented group and a placebo-supplemented (control) group. The subjects aged between 18 – 45 years and totaling 180. RESULTS: Total of 50 (28%) of the participating were hypertensive defined as Systolic Blood Pressure (SBP) ≥140 mmHg. The mean SBP of lysine-supplemented group significantly dropped from 146.11 ± 11.92 to 128.95 ± 10.44 mmHg (p = 0.02). That of women also dropped from 144.12 ± 10.41 to 132.28 ± 10.69 mmHg, (p = 0.06 while the control group had there SBP remained fairly constant after 112 days of intervention with changes in men from 145.79 ± 12.56 to 142.79 ± 11.07 mmHg (p = 0.32) and women in the control had very little drop from 145.15 ± 14.79 to 145.00 ± 17.93 mmHg (p = 0.96). CONCLUSION: Lysine supplementation resulted in normalization/reduction of blood pressure of hypertensive subjects who have suboptimal lysine intake.
1000 Sacherschließung
lokal Placebo
lokal Lysine
lokal Supplementation
lokal Hypertension
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/creator/VnV2b3IsIEZyZWRlcmljaw==|https://frl.publisso.de/adhoc/creator/TW9oYW1tZWQsIEh1c2Vpbg==|https://frl.publisso.de/adhoc/creator/TmRhbnUsIFRob21hcw==|https://frl.publisso.de/adhoc/creator/SGFycmlzb24sIE9iZWQ=
1000 Label
1000 Förderer
  1. Ajinomoto Company (France) |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Ajinomoto Company (France) |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6410550.rdf
1000 Erstellt am 2018-10-11T14:45:37.394+0200
1000 Erstellt von 218
1000 beschreibt frl:6410550
1000 Bearbeitet von 218
1000 Zuletzt bearbeitet Fri Sep 03 15:47:06 CEST 2021
1000 Objekt bearb. Fri Sep 03 15:47:05 CEST 2021
1000 Vgl. frl:6410550
1000 Oai Id
  1. oai:frl.publisso.de:frl:6410550 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source